New cancer drugs being held back to save Government money, says GlaxoSmithKline boss

The head of Britain biggest drugs company has accused the Government of systematically delaying the introduction of new cancer drugs in order to save money.
The Telegraph
Mar. 01, 2012

GlaxoSmithKline chief executive Sir Andrew Witty warned that ministers were making false economies as they tried to grapple with the deficit in the public finances.

Read More

All original InformationLiberation articles CC 4.0

About Us - Disclaimer - Privacy Policy